Activity of Telavancin against Staphylococcus aureus Isolates, Including Those with Decreased Susceptibility to Ceftaroline, from Cystic Fibrosis Patients

Melanie Roch, Maria Celeste Varela, Agustina Taglialegna, Warren E. Rose, Adriana E. Rosato
  • Antimicrobial Agents and Chemotherapy, June 2018, ASM Journals
  • DOI: 10.1128/aac.00956-18

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1128/aac.00956-18

In partnership with: